Trevor Freeman

History

Blog: View recent blog entries
Member for: 3 years 9 months

Author Articles

Drug Abuse in the States: Treatment

Tuesday, October 3, 2017 at 03:33 PM

Drug abuse is a crisis in the United States that only continues to grow over time. Many states have turned to treatment plans in efforts to slow this trend. The third installment of this research series will examine what states are doing about drug abuse treatment policies.

Kentucky Work Matters Task Force Meeting Resources

Trevor Freeman

Monday, September 18, 2017 at 02:48 PM

On September 27^th, 2017, the Kentucky Work Matters Task Force will convene once again to discuss disability employment policies. This task force was convened by Governor Matt Bevin in June of 2017. The mission of the Kentucky Work Matters Task Force is “to address barriers to employment and promote workforce inclusion among people with disabilities, foster children, disabled veterans, individuals with substance abuse issues and individuals with...

Drug Abuse in the States: Incarceration

Trevor Freeman

Monday, August 28, 2017 at 03:14 PM

Addiction is a driving force for drug abuse. Addiction causes people to do whatever it takes to get ahold of their drug of choice. Often the acquisition of drugs leads to people getting arrested and incarcerated. The second installment of this series will examine how drug abuse in the states affects incarceration.

Gabapentin Abuse: Some Questions and Answers

Trevor Freeman

Tuesday, August 15, 2017 at 10:47 AM

Over the years, substance abuse trends in the states have shift from one drug to another as new policy solutions make previously abused drugs more scarce. Over the past decade, gabapentin has emerged as a drug of concern. Gabapentin, the generic for Neurontin, is a medication that was approved by the FDA in 1993 and is approved to treat epilepsy and nerve pain caused by shingles. The IMS Institute...

Drug Abuse in the States

Trevor Freeman

Thursday, August 10, 2017 at 10:58 AM

Drug abuse is an ever-growing epidemic in the United States. In a series of research briefs, CSG will examine the effects of drug abuse on the states through incarceration, treatment and the workforce.

FDA Makes Unprecedented Move Against Opioid Medication

Trevor Freeman

Monday, July 17, 2017 at 01:45 PM

On June 8, 2017, the Food and Drug Administration, or FDA, publicly requested that Endo Pharmaceuticals remove their drug, Opana ER, from the market. The agency stated that the benefits of the medication no longer outweighs the risks. According to the FDA, there has been a shift in abuse that has seen an increase in crushing, snorting and injecting the medication. This increase in injection abuse has also seen an increase in HIV and Hepatitis C...